InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-32.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Anderson Kenneth Carl, Director. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 23 filings have been logged. History available since 2 July 2021. The latest transaction was filed on 1 June 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations23 total
2,650 sharesCommon StockSEC:0001470831-26-000688:0
1,070 shares@ US$2.110.0004% mcap1.1% of flowCommon StockSEC:0001470831-26-000504:0
4,259 shares@ US$2.705.4% of flowCommon StockSEC:0001470831-26-000346:0
7,616 shares@ US$1.51Common StockSEC:0001662579-25-000053:0
7,841 shares@ US$1.4356.1% of flowCommon StockSEC:0001662579-25-000024:0
3,074 shares@ US$3.666.3% of flowCommon StockSEC:0001662579-25-000003:0
2,023 shares@ US$5.565.9% of flowCommon StockSEC:0001662579-24-000089:0
2,320 shares@ US$4.856.1% of flowCommon StockSEC:0001662579-24-000063:0
1,389 shares@ US$8.106.1% of flowCommon StockSEC:0001662579-24-000038:0
1,725 shares@ US$6.525.9% of flowCommon StockSEC:0001662579-24-000005:0
6,617 shares@ US$1.706.3% of flowCommon StockSEC:0001662579-23-000109:0
3,976 shares@ US$2.836.0% of flowCommon StockSEC:0001662579-23-000068:0
3,516 shares@ US$3.206.0% of flowCommon StockSEC:0001662579-23-000045:0
268 shares@ US$2.110.3% of flowCommon StockSEC:0001662579-23-000008:0
1,568 shares@ US$6.385.5% of flowCommon StockSEC:0001662579-23-000006:0
267 shares@ US$2.110.3% of flowCommon StockSEC:0001662579-22-000004:0
535 shares@ US$2.110.7% of flowCommon StockSEC:0001209191-22-042457:0
1,246 shares@ US$8.035.6% of flowCommon StockSEC:0001209191-22-040597:0
341 shares@ US$26.460.0044% mcap14.5% of flowCommon StockSEC:0001209191-22-023016:0
803 shares@ US$2.110.0008% mcap2.7% of flowCommon StockSEC:0001209191-22-005107:0
278 shares@ US$31.580.0042% mcap13.7% of flowCommon StockSEC:0001209191-22-003500:0
194 shares@ US$44.990.0041% mcap13.3% of flowCommon StockSEC:0001209191-21-059515:0
220 shares@ US$39.720.0040% mcap13.0% of flowCommon StockSEC:0001209191-21-045806:0
23 of 23 declarations
About Anderson Kenneth Carl
Anderson Kenneth Carl serves as a Board Member at C4 Therapeutics, Inc. He is involved in overseeing the company's operations and strategic decisions. Kenneth brings expertise in biotechnology and research, which is essential for the development of C4 Therapeutics' business. His role on the board contributes to growth and innovation.
